Skip to main content

Onkologische Grundlagen und Molekulargenetik von ZNS-Tumoren im Kindes- und Jugendalter

  • Chapter
  • First Online:
Pädiatrische Neurochirurgie
  • 4644 Accesses

Zusammenfassung

Das Auftreten von Hirntumoren im Kindes- und Jugendalter ist eng mit der Entwicklung des Zentralnervensystems verknüpft, während der viele unterschiedliche Zellpopulationen über einen gewissen Zeitraum anfällig für tumorauslösende Veränderungen sein können. Dies spiegelt sich in der enormen Vielfalt von Tumorarten wider, von denen einige häufiger, andere sehr selten auftreten und die oft eine umschriebene Altersgruppe betreffen. Das Spektrum reicht von benignen, langsam wachsenden bis hin zu hochgradig aggressiven Tumoren. Die Unterscheidung erfolgt bislang hauptsächlich nach dem histopathologischen Erscheinungsbild der Tumorzellen. In vielen dieser Tumorarten finden sich charakteristische genetische und epigenetische Veränderungen, die zunehmend Einzug in die Klassifikation finden, Aussagen über den Krankheitsverlauf zulassen und zielgerichtete Therapiestrategien ermöglichen. Die derzeitige Behandlung besteht in den meisten Fällen in der operativen Tumorentfernung und einer Kombination von adjuvanter Strahlen- und Chemotherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Literatur

  • Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79

    CAS  PubMed  Google Scholar 

  • Cage TA, Clark AJ, Aranda D, Gupta N, Sun PP, Parsa AT, Auguste KI (2013) A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. J Neurosurg Pediat 11:673–681

    Article  Google Scholar 

  • Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, Zhao W, Nicholson SL, Taylor RE, Bailey S et al. (2011) Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical pathologic and molecular variables. J Clin Oncol 29:1400–1407

    Article  Google Scholar 

  • Gajjar AJ, Robinson GW (2014) Medulloblastoma-translating discoveries from the bench to the bedside. Nat Rev Clin Oncol 11:714–722

    Article  CAS  Google Scholar 

  • Gajjar A, Stewart CF, Ellison DW, Kaste S, Kun LE, Packer RJ, Goldman S, Chintagumpala M, Wallace D, Takebe N et al. (2013) Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clin Cancer Res 19:6305–6312

    Article  CAS  Google Scholar 

  • Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG (2015) Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. J Clin Oncol 33:2986–2998

    Article  CAS  Google Scholar 

  • Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stutz AM et al. (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100–105

    Article  CAS  Google Scholar 

  • Jones DT, Hutter B, Jager N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA et al. (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927–932

    Article  CAS  Google Scholar 

  • Judkins AR, Mauger J, Ht, A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650

    Article  Google Scholar 

  • Kilday JP, Mitra B, Domerg C, Ward J, Andreiuolo F, Osteso-Ibanez T, Mauguen A, Varlet P, Le Deley MC, Lowe J et al. (2012) Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clin Cancer Res 18:2001–2011

    Article  CAS  Google Scholar 

  • Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M et al. (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393–405

    Article  CAS  Google Scholar 

  • Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schottler A et al. (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28:3182–3190

    Article  Google Scholar 

  • Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DT, Remke M, Northcott P, Perry A, Picard D et al. (2014) Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128:279–289

    Article  Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO Classification of tumors of the central nervous system. IARC, Lyon

    Google Scholar 

  • Mack SC, Witt H, Piro RM, Gu, L, Zuyderduyn S, Stutz AM, Wang X, Gallo M, Garzia L, Zayne K et al. (2014) Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506:445–450

    Article  CAS  Google Scholar 

  • Merchant TE, Li, C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. The Lancet Oncology 10:258–266

    Article  Google Scholar 

  • Morfouace M, Shelat A, Jacus M, Freeman BB, 3rd, Turner D, Robinson S, Zindy F, Wang YD, Finkelstein D, Ayrault O et al. (2014) Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma. Cancer cell 25:516–529

    Article  CAS  Google Scholar 

  • Northcott PA, Lee C, Zichner T, Stutz AM, Erkek S, Kawauchi D, Shih DJ, Hovestadt V, Zapatka M, Sturm D et al. (2014) Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511:428–434

    Article  CAS  Google Scholar 

  • Northcott PA, Pfister SM, Jones DT (2015) Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies. Lancet Oncol 16:e293–302

    Article  Google Scholar 

  • Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2016) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013. Neuro Oncol 18 (Suppl 5): v1–v75. https://doi.org/10.1093/neuonc/now207

    Article  PubMed  Google Scholar 

  • Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P et al. (2015) Molecular Classification of Ependymal Tumors across All CNS Compartments Histopathological Grades and Age Groups. Cancer Cell 27:728–743

    Article  CAS  Google Scholar 

  • Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li, Y, Lee R, Tatevossian RG, Phoenix TN, Thiruvenkatam R et al. (2014) C11orf95–RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506:451–455

    Article  CAS  Google Scholar 

  • Pejavar S, Polley MY, Rosenberg-Wohl S, Chennupati S, Prados MD, Berger MS, Banerjee A, Gupta N, Haas-Kogan D (2012) Pediatric intracranial ependymoma: the roles of surgery radiation and chemotherapy. J Neurooncol 106:367–375

    Article  Google Scholar 

  • Purdy E, Johnston DL, Bartels U, Fryer C, Carret AS, Crooks B, Eisenstat DD, Lafay-Cousin L, Larouche V, Wilson B et al. (2014) Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium. J Neurooncol 117:359–364

    Article  Google Scholar 

  • Rausch T, Jones DT, Zapatka M, Stutz AM, Zichner T, Weischenfeldt J, Jager N, Remke M, Shih D, Northcott PA et al. (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148:59–71

    Article  CAS  Google Scholar 

  • Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu, L, Holcomb T, Stinson J, Gould SE, Coleman B et al. (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173–1178

    Article  CAS  Google Scholar 

  • Schwartzentruber J, Korshunov A, Liu XY, Jones DTW Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231

    Article  CAS  Google Scholar 

  • Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tonjes M, Sill M, Bender S et al. (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437

    Article  CAS  Google Scholar 

  • Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW Capper D, Sill M, Buchhalter I, Northcott PA, Leis I et al. (2016) New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell 164(5):1060–1072

    Article  CAS  Google Scholar 

  • Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A et al. (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol123:465–472

    Article  Google Scholar 

  • Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206

    Article  CAS  Google Scholar 

  • Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, Benner A, Hielscher T, Milde T, Remke M et al. (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20:143–157

    Article  CAS  Google Scholar 

  • Wu, G, Broniscer A, McEachron TA, Lu, C, Paugh BS, Becksfort J, Qu, C, Ding L, Huether R, Parker M et al. (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251–253

    Article  CAS  Google Scholar 

  • Zhang J, Wu, G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I et al. (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Sturm .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sturm, D., Pfister, S.M., Witt, H. (2018). Onkologische Grundlagen und Molekulargenetik von ZNS-Tumoren im Kindes- und Jugendalter. In: Bächli, H., Lütschg, J., Messing-Jünger, M. (eds) Pädiatrische Neurochirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48700-6_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48700-6_32

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48699-3

  • Online ISBN: 978-3-662-48700-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics